RGRX OTC
RegeneRx Biopharmaceuticals, Inc.
1W: +0.0%
1M: +57.1%
3M: +83.3%
YTD: +266.7%
1Y: +450.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$382K
-70.3% ▼
5Y CAGR: +11.0%
Total Liabilities
$4M
+8.9% ▲
5Y CAGR: -2.5%
Shareholders Equity
-$3M
-54.5% ▼
Cash & Investments
$291K
-76.4% ▼
5Y CAGR: +9.9%
Total Debt
$1M
+24.2% ▲
5Y CAGR: +17.9%
Net Debt
$1M
+1832.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $237K | $640K | $428K | $1M | $291K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $237K | $640K | $428K | $1M | $291K |
| Net Receivables | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $29K | $14K | $11K | $14K | $6K |
| Total Current Assets | $274K | $682K | $478K | $1M | $307K |
| Property, Plant & Equip. | $1K | $24K | $68K | $28K | $70K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $6K | $6K | $6K | $6K | $6K |
| Total Non-Current Assets | $7K | $30K | $74K | $33K | $75K |
| Total Assets | $281K | $712K | $552K | $1M | $382K |
| — Liabilities — | |||||
| Accounts Payable | $92K | $44K | $39K | $64K | $64K |
| Short-Term Debt | $55K | $27K | $34K | $28K | $43K |
| Deferred Revenue | $77K | $77K | $77K | $77K | $77K |
| Other Current Liabilities | $56K | $52K | $180K | $212K | $290K |
| Total Current Liabilities | $315K | $242K | $400K | $430K | $554K |
| Long-Term Debt | $0 | $708K | $924K | $1M | $1M |
| Other Non-Current Liab. | $0 | $0 | $0 | $2M | $2M |
| Total Non-Current Liabilities | $2M | $3M | $3M | $3M | $3M |
| Total Liabilities | $2M | $3M | $3M | $4M | $4M |
| — Equity — | |||||
| Common Stock | $128K | $132K | $133K | $144K | $144K |
| Retained Earnings | -$106M | -$107M | -$109M | -$110M | -$112M |
| Accumulated OCI | -$98K | $0 | $0 | $0 | $0 |
| Total Stockholders Equity | -$2M | -$2M | -$3M | -$2M | -$3M |
| Total Liabilities & Equity | $281K | $712K | $552K | $1M | $382K |
| — Key Metrics — | |||||
| Total Debt | $55K | $735K | $1M | $1M | $1M |
| Net Debt | -$183K | $95K | $598K | -$67K | $1M |
| Total Investments | $0 | $0 | $0 | $0 | $0 |